Keywords: Lp (a)، لیپوپروتئین (a); AUC, area under the curve; BMI, body mass index; CUN, University of Navarra Clinic; FPG, fasting plasma glucose; HDL-C, HDL cholesterol; HR, hazard ratio; IFG, impaired fasting glucose; IR, insulin resistance; Lp(a), lipoprotein(a); LDL-C, LDL cholesterol
مقالات ISI Lp (a)، لیپوپروتئین (a) (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Supplementation with coenzyme Q10 reduces plasma lipoprotein(a) concentrations but not other lipid indices: A systematic review and meta-analysis
Keywords: Lp (a)، لیپوپروتئین (a); Lp(a), lipoprotein(a); CVD, cardiovascular disease; CETP, cholesteryl ester transport protein; PCSK9, proprotein convertase subtilisin/kexin type 9; CoQ10, coenzyme Q10; BMI, body mass index; LDC-C, low-density lipoprotein cholesterol; HDL-C, high-density
Relationships of plasma lipoprotein(a) levels with insulin resistance in hypertensive patients
Keywords: Lp (a)، لیپوپروتئین (a); Lp(a), lipoprotein(a); LDL, low-density lipoproteins; Apo(a), apolipoprotein(a); BMI, body mass index; TIA, transitory ischemic attack; ELISA, enzyme linked immunosorbent assay; HOMA, homeostatic model assessment; G-AUC, area under the curve for glucose r
Translating the basic knowledge of mitochondrial functions to metabolic therapy: role of L-carnitine
Keywords: Lp (a)، لیپوپروتئین (a); ATP, adenosine-5'-triphosphate; BP, blood pressure; CoA, coenzyme A; CoASH, free coenzyme A; eNOS, endothelial nitric oxide synthase; FA, fatty acid; Lp(a), lipoprotein(a); NO, nitric oxide; OXPHOS, oxidative-phosphorylation system; ROS, reactive oxygen s
Lipoprotein(a) metabolism: Potential sites for therapeutic targets
Keywords: Lp (a)، لیپوپروتئین (a); LPA, apolipoprotein(a) gene; Lp(a), lipoprotein(a); LDL, low density lipoprotein; apoB, apolipoprotein B; apo(a), apolipoprotein(a); Plg, plasminogen; C-terminal, carboxy terminal end polypeptide chain; N-terminal, amino terminal end polypeptide chain; CV
Interaction between homocysteine and lipoprotein(a) increases the prevalence of coronary artery disease/myocardial infarction in women: A case-control study
Keywords: Lp (a)، لیپوپروتئین (a); Hcy, homocysteine; Lp(a), lipoprotein(a); CAD, coronary artery disease; CI, 95% confidence interval; MI, myocardial infarction; OR, odds ratio; MTHFR, methylene tetrahydrofolate reductase; LDL, low density lipoproteine; HDL, high density lipoproteine; MTH
Lipoprotein(a) as a Potential Causal Genetic Risk Factor of Cardiovascular Disease : A Rationale for Increased Efforts to Understand its Pathophysiology and Develop Targeted Therapies
Keywords: Lp (a)، لیپوپروتئین (a); cardiovascular disease; Lp(a); therapyapo(a), apolipoprotein(a); CVD, cardiovascular disease; HDL-C, high-density lipoprotein cholesterol; K, kringle; LDL-C, low-density lipoprotein cholesterol; Lp(a), lipoprotein(a); OxPL, oxidized phospholipids; SNP, si
Percutaneous coronary intervention results in acute increases in native and oxidized lipoprotein(a) in patients with acute coronary syndrome and stable coronary artery disease
Keywords: Lp (a)، لیپوپروتئین (a); Lp(a), lipoprotein(a); LDL, low density lipoprotein; apo, apolipoprotein; ox-Lp(a), oxidized Lp(a); IC, immune complexes; ox-LDL, oxidized LDL; CAD, coronary artery disease; ACS, acute coronary syndrome; PCI, percutaneous coronary intervention; ELISA, enz
Apolipoprotein(a) Isoforms and the Risk of Vascular Disease : Systematic Review of 40 Studies Involving 58,000 Participants
Keywords: Lp (a)، لیپوپروتئین (a); lipoprotein(a); apolipoprotein(a) isoforms; cardiovascular disease; meta-analysis; epidemiologyapo(a), apolipoprotein(a); CHD, coronary heart disease; KIV2, kringle IV type 2; LDL, low-density lipoprotein; Lp(a), lipoprotein(a); MI, myocardial infarction;
Prognostic Value of Plasma Fibrinolysis Activation Markers in Cardiovascular Disease
Keywords: Lp (a)، لیپوپروتئین (a); biomarker; cardiovascular; D-dimer; fibrinolysis; lipoprotein (a); PAI-1; TPAACS, acute coronary syndrome; AMI, acute myocardial infarction; CAD, coronary artery disease; ELISA, enzyme-linked immunoadsorbent assay; HR, hazard ratio; Lp(a), lipoprotein(a);
Oxidation-Specific Biomarkers, Lipoprotein(a), and Risk of Fatal and Nonfatal Coronary Events
Keywords: Lp (a)، لیپوپروتئین (a); atherosclerosis; biomarkers; myocardial infarction; oxidationCAD, coronary artery disease; CI, confidence interval; CVD, cardiovascular disease; FRS, Framingham Risk Score; LDL, low-density lipoprotein; Lp(a), lipoprotein(a); Lp-PLA2, lipoprotein-associat
The apo(a) gene (TTTTA)n promoter polymorphism and its association with variability in exons of the kringle IV types 8 to 10
Keywords: Lp (a)، لیپوپروتئین (a); apo(a), apolipoprotein(a); HRM, high resolution melting; K, kringle (protein domain); Lp(a), lipoprotein(a); PCR, polymerase chain reaction; STR, short tandem repeat, herein the TTTTA repetitionApolipoprotein(a); Haplotypes; Lipoprotein(a); Polymorphism;
A Kinesin Family Member 6 Variant Is Associated With Coronary Heart Disease in the Women’s Health Study
Keywords: Lp (a)، لیپوپروتئین (a); CHD, coronary heart disease; HDL-C, high-density lipoprotein cholesterol; HWE, Hardy-Weinberg equilibrium; LDL-C, low-density lipoprotein cholesterol; Lp(a), lipoprotein(a); MI, myocardial infarction
Native, oxidized lipoprotein(a) and lipoprotein(a) immune complex in patients with active and inactive rheumatoid arthritis: Plasma concentrations and relationship to inflammation
Keywords: Lp (a)، لیپوپروتئین (a); RA, Rheumatoid arthritis; Lp(a), Lipoprotein(a); ox-, oxidized; IC, immune complex; CHD, coronary heart disease; DMADs, disease modifying antirheumatic drugs; ESR, erythrocyte sedimentation rate; CRP, C-reactive protein; AU, absorbance unit; TC, total cho
Evaluation of an HPLC method for LDL-cholesterol determination in patients with various lipoprotein abnormalities in comparison with beta-quantification
Keywords: Lp (a)، لیپوپروتئین (a); TC, total cholesterol; CHD, coronary heart disease; LDL, low-density lipoprotein; ATP, Adult Treatment Panel; LDL-C, LDL-cholesterol; BQ, β-quantification; HDL-C, HDL-cholesterol; IDL, intermediate-density lipoprotein; Lp(a), lipoprotein(a); TG, triglycer
Analysis of traditional and nontraditional risk factors for peripheral arterial disease in elderly type 2 diabetic patients in Taiwan
Keywords: Lp (a)، لیپوپروتئین (a); ABI, ankle-brachial index; AER, albumin excretion rate; BMI, body-mass index; CVD, cardiovascular disease; CKD, chronic kidney disease; DM, diabetes mellitus; hsCRP, high sensitive cross reactive protein; Lp(a), lipoprotein(a); PAD, peripheral artery dise
Multicentric evaluation of the homogeneous LDL-cholesterol Plus assay: Comparison with beta-quantification and Friedewald formula
Keywords: Lp (a)، لیپوپروتئین (a); BQ, LDL-C by beta-quantification; CM, chylomicrons; DIR, LDL-C by the direct LDL-C Roche Plus; FF, LDL-C calculated by the Friedewald formula; HDL-C, HDL-cholesterol; IDL, intermediate-density lipoproteins; LDL-C, LDL-cholesterol; Lp(a), lipoprotein(a); N
Development of new enzyme-linked immunosorbent assay for oxidized lipoprotein(a) by using purified human oxidized lipoprotein(a) autoantibodies as capture antibody
Keywords: Lp (a)، لیپوپروتئین (a); Lp(a), Lipoprotein(a); LDL, low density lipoprotein; apo, apolipoprotein; ox, oxidized; MDA, malondialdehyde; CHD, coronary heart disease; ELISA, enzyme-linked immunosorbent assays; HDL, high density lipoprotein.Lipoprotein(a); Oxidative modification; Aut
Carotid atherosclerosis and cardiovascular risk factors in hemodialysis and peritoneal dialysis patients
Keywords: Lp (a)، لیپوپروتئین (a); HD, hemodialysis; PD, peritoneal dialysis; IMT, carotid artery intima media thickness; PS, plaque score; apo A-l, apolipoprotein A-l; apo B, apolipoprotein B; Lp(a), lipoprotein(a); hs-CRP, high-sensitivity CRP; Hcy, homocysteine; SA, sialic acid; TBARS,
Association between inflammation, lipid and hemostatic factors in patients with stable angina
Keywords: Lp (a)، لیپوپروتئین (a); Lp(a), lipoprotein(a); BMI, body mass index; CRP, C-reactive protein; Apo A1, apolipoprotein A1; Apo B100, apolipoprotein B100; HDLc, HDLC-cholesterol; LDLc, LDL-cholesterolInflammation; Lipids; Hemostatic factors; Thrombosis; Stable angina
Relative quantification of glycosaminoglycan-induced upregulation of TFPI-mRNA expression in vitro
Keywords: Lp (a)، لیپوپروتئین (a); AU, arbitrary units; CS, chondroitin sulfate; GAG, glycosaminoglycan; HS, heparan sulfate; Lp(a), lipoprotein(a); LMWH, low-molecular-weight heparin; UFH, unfractionated heparin; TF, tissue factor; TFPI, tissue factor pathway inhibitorTissue factor pathwa
Relation Between Lipoprotein(a) and Fibrinogen and Serial Intravascular Ultrasound Plaque Progression in Left Main Coronary Arteries
Keywords: Lp (a)، لیپوپروتئین (a); CI, confidence interval; CSA, cross-sectional area; EEM, external elastic membrane; HDL, high-density lipoprotein; IVUS, intravascular ultrasound; LDL, low-density lipoprotein; Lp(a), lipoprotein(a); PCI, percutaneous coronary intervention; P&M, plaque pl
Electroelution of lipoprotein(a) [Lp(a)] from native polyacrylamide gels: A new, simple method to purify Lp(a)
Keywords: Lp (a)، لیپوپروتئین (a); Lp(a), lipoprotein(a); Apo(a), apolipoprotein(a); LDL, low density lipoprotein; HDL, high density lipoprotein; HDL2, high density lipoprotein subclass 2 (density 1.063–1.125 g/ml); IDL, intermediate density lipoprotein; TBE, tris-boric acid-EDTA; ID, inne